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INTRODUCTION 18
Zika virus (ZIKV; Flaviviridae, Flavivirus) is primarily transmitted by Aedes aegypti mosquitoes, 19 but animal models of ZIKV pathogenesis have relied on needle inoculation [1] [2] [3] [4] [5] [6] [7] . Needle 20 inoculation has been performed using a range of doses, delivered subcutaneously at a single 21 site or at multiple sites, as well as intravenously, intravaginally, intrarectally, and intra-22 amniotically in pregnant animals. Each of these routes and inoculum doses could modulate viral 23 infection kinetics and viral tissue distribution on their own, but none of them entirely recapitulate 24 vector delivery of the virus. Blood feeding by a mosquito ensures delivery of the virus to an 25 anatomically precise target in the dermis of the skin [8] [9] [10] . When a mosquito feeds it inserts its 26 mouthparts into the skin and then actively probes within the tissue for blood. When blood is 27 found, the mosquito begins feeding either directly from the vessel or from the resulting 28 hemorrhage. Importantly, the majority of the inoculum delivered by a mosquito while probing 29 and feeding is deposited extravascularly 11 and only a small amount (~10 2 plaque-forming units 30 (PFU)) is deposited intravascularly 12 . Throughout this process, a mosquito injects saliva into the 31 host. The saliva of hematophages, including mosquitoes, is a cocktail of potent 32 pharmacologically active components that prevents clotting and causes vasodilation, as well as 33 alters the inflammatory and immune response, to help facilitate blood feeding 13-15 . 34 Pathogens such as ZIKV exploit this system to infect new vertebrate hosts. Mosquito saliva 35 enhances the replication and pathogenesis of numerous arthropod-borne viruses 16-21 . 36 Furthermore, mosquito saliva has been shown to alter virus dissemination in mammalian hosts 37 for other arboviruses such as dengue virus and Semliki Forest virus 22, 23 . Therefore, saliva 38 delivered to the host by a mosquito may have a critical impact on the initial infection in the skin 39 and may modulate the local innate and adaptive immune response. Accordingly, needle delivery 40 may fail to fully recapitulate important biological parameters of natural ZIKV infection. In 41 addition, the delivery of isolated, purified pathogens by needle inoculation can introduce 42 significant artifacts into the system: for example, directly inoculated virus stocks contain cell 43 culture components not found in mosquito saliva. In sum, it is impossible to replicate the 44 biological, physiological, and mechanical phenomena of mosquito feeding and/or probing using 45 a needle. 46 The amount of ZIKV inoculated by mosquitoes into a host is not known. In the majority of our 47 previous studies we used an inoculum dose of 1 x 10 4 PFU injected subcutaneously (sc) 1,2,24 , 48 which we chose as a dose likely to be delivered by a ZIKV-infected mosquito. This was based 49 on previous studies, which found that mosquitoes delivered ~1 x 10 4 -1 x 10 6 PFU of West Nile 50 virus (WNV) 12 and as much as 1 x 10 4 50% mosquito infectious doses of dengue virus (DENV) 51 25 . Other recent studies of ZIKV infection in nonhuman primates have relied on a variety of 52 doses and routes with varying outcomes. For example, five sc inoculations each containing 1 x 53 10 7 PFU (a 50-fold higher cumulative dose than any other published study) of a Cambodian 54 strain of ZIKV in a pregnant pigtail macaque (Macaca nemestrina) resulted in severe fetal 55 neurodevelopmental abnormalities not seen in other studies using a smaller dose of different 56 ZIKV strains 5 . In rhesus and cynomolgus macaques (Macaca mulatta and Macaca fascicularis, 57 respectively), ZIKV RNA persisted in saliva and seminal fluids for at least three weeks after 58 clearance of the virus from the peripheral blood following sc inoculation with 1 x 10 6 PFU of a 59
Thai ZIKV isolate 26 . Our studies using the same route and doses ranging from 1 x 10 4 to 1 x 10 6 60 PFU of a French Polynesian isolate showed no persistence in body fluids after the resolution of 61 acute plasma viremia in non-pregnant macaques 2 . In yet another study in rhesus macaques, 62 intravenous administration of 1 x 10 5 PFU of a Brazilian ZIKV isolate resulted in a short-lived 63 plasma viremia and vRNA distribution in a variety of tissues two weeks post-infection 7 . 64
Together these studies established that Asian/American lineage ZIKV infection of rhesus 65 macaques provides a relevant animal model for studying natural history and pathogenesis in a 66 host that has salient similarities to human pregnancy and biology. But they also highlight that 67 differences in route, dose and virus strain may lead to different outcomes. Although no studies 68 to date have addressed whether infection via needle inoculation fundamentally differs from 69 infection via a mosquito vector, transmission of ZIKV via mosquito was attempted in 1956 in 70
Nigeria, but only seroconversion was observed 27 . 71
Here, we show that ZIKV-infected Ae. aegypti can reliably initiate systemic ZIKV infections in 72 rhesus macaques. To assess differences in ZIKV replication between virus delivery by needle 73 versus mosquito vector, we infected rhesus macaques with the Puerto Rican ZIKV isolate 74 PRVABC59 by either sc inoculation (n=3) or by exposure to infected mosquitoes (n=4). All three 75 sc-inoculated macaques were productively infected, with viral load dynamics similar to what we 76 have reported previously 1, 2 . All four animals exposed to Ae. aegypti were also productively 77 infected, with noticeable differences in peak viral load and the time to peak viral load. 78
RESULTS 79

Mosquito-bite delivery of ZIKV results in systemic infection in macaques. To generate 80
ZIKV-infected mosquitoes, adult female Ae. aegypti were fed on ZIKV-infected Ifnar-/-mice. 81
Twelve days (d) post-feeding (PF), these same mosquitoes then were allowed to feed on ZIKV-82 naive macaques. All macaques (n=4) exposed to probing and/or feeding of ZIKV-exposed 83 mosquitoes developed systemic infections as measured by the presence of vRNA in blood 84 plasma (Figure 1 ). Since not all mosquitoes bite animals under experimental conditions, we 85 used visual engorgement with blood as a sign of biting and injection of ZIKV. All mosquitoes that 86 fed took a full bloodmeal (indicated by a fully engorged, distended abdomen) and only those 87 mosquitoes that fed also probed. One macaque (328696) received 18 bites, one macaque 88 (349332) received 8 bites, and two macaques (268283 and 458001) received 5 bites. After 89 macaque feeding, mosquito vector competence for ZIKV was tested on a subset of the same 90
Ae. aegypti (n=40) using an in vitro transmission assay 28,29 at 12 d PF, the same time point as 91 the mosquitoes fed on the macaques. As expected, the infection (90%) and dissemination 92 (83%) rates were high for Ae. aegypti exposed to ZIKV-infected mice, while the transmission 93 rate was more moderate (25%; Table 1 ). Infection efficiency indicates the proportion of 94 mosquitoes with virus-positive bodies among the tested ones. Dissemination efficiency indicates 95 the proportion of mosquitoes with virus-positive legs, and transmission efficiency indicates the 96 proportion of mosquitoes with infectious saliva among the tested ones. We used plaque assays 97 on collected saliva to estimate the ZIKV dose inoculated by mosquitoes and found that Ae. 98 aegypti saliva titers ranged from 10 1.5 to 10 3.2 PFU (Figure 2) . Importantly, collection of 99 mosquito saliva via capillary feeding does not allow mosquitoes to probe and feed naturally and 100 therefore likely underestimates the dose of virus inoculated. In fact, mosquitoes probing and 101 feeding on a living host delivered doses of other flaviviruses that were 10-to 1000-fold higher 102 than those measured using in vitro methods 12 . 103 Mosquito-bite infection results in a delay to peak viral load. To examine whether viral 104 replication kinetics differed between virus delivery from a needle and delivery from a mosquito 105 vector, we compared viral load dynamics in sc-inoculated animals and animals infected via 106 mosquito bites. There were noticeable differences in peak viral load and the time to peak viral 107 load ( Figure 1 ). Viral loads in macaques sc-inoculated with 1 x 10 4 PFU of ZIKV-PR peaked in 108 all three animals at 3 dpi, and ranged from 9.32 x 10 4 to 3.85 x 10 5 vRNA copies/ml, while viral 109 loads peaked at 5 or 6 dpi and ranged from 5.83 x 10 4 to 4.40 x 10 6 vRNA copies/ml in animals 110 that received mosquito bites. Peak viral loads did not differ significantly (Student's t-test) 111 between sc-inoculated animals and mosquito-bitten animals (p-value=0.305, t-value=1.144, 112 df=5); however, peak viral load occurred significantly faster in sc-inoculated animals (linear 113 mixed-effects model; p-value=0.006, t-value=-7.606, df=5). Antibody responses were generated 114 rapidly in both sc-inoculated and mosquito-bitten animals, with detectable changes in IgM as 115 early as 10 dpi ( Supplementary Table 1 ). 116
ZIKV tissue distribution in mosquito-challenged animals is similar to sc-inoculated 117
animals. To assess whether vRNA levels and tissue tropism differed after virus delivery from 118 needle versus delivery by mosquito vector, we used qRT-PCR to measure ZIKV RNA in 119 homogenized macaque tissues. At 15 dpi, both sc-inoculated and mosquito-bite challenged 120 animals were euthanized and tissues collected. In mosquito-bitten animals hemolymphatic 121 tissues contained the highest levels of detectable vRNA. Lymph nodes and spleen were the 122 most highly positive, ranging from 3.1 x 10 2 to 1.8 x 10 5 vRNA copies/mg of tissue at 15 days 123 PF (Figure 3 ). Kidney and liver also were positive; and in the female animal, 458001, 124 reproductive tract tissues were positive ( Figure 3 ). Notably brain, ocular, and male reproductive 125 tract tissues from all animals contained no detectable vRNA (see Table 2 for a list of all tissues 126 collected and screened). In sc-inoculated animals, hemolymphatic tissues also contained the 127 highest levels of detectable vRNA in both animals (one animal was excluded because tissues 128
were not collected with sterile instruments). Similar to mosquito bitten animals, kidney, liver, and 129 female reproductive tract tissues also contained detectable vRNA; whereas, male reproductive 130 tract tissues contained no detectable ZIKV RNA. In contrast to mosquito bitten animals, ZIKV 131 RNA was detected in the cerebrum of 566628 and the eye of both sc-inoculated animals 132 Supplementary Table  140 3). For comparison, we characterized viral SNPs in the 3 monkeys infected by sc injection with 1 141
x 10 4 PFU of the same virus stock. ZIKV sequences from these samples were assembled to a 142 ZIKV-PRVABC59 reference sequence (Genbank KU501215). Across all samples, we detected 143 42 SNPs occurring in one or more samples at a frequency of ≥5% throughout the viral coding 144 genome ( Figure 4 ). Of these, 9 SNPs occurred in structural genes, 33 in nonstructural genes. In 145 sc-infected monkeys, the frequency and distribution of viral SNPs were highly similar among 146 infected animals and closely resembled those observed in the stock virus ( Figure 4A) . By 147 contrast, viral populations in infected mosquitoes, and in monkeys infected by these 148 mosquitoes, showed a heterogeneous pattern of SNPs, with fewer SNPs shared among 149 samples (Figure 4B-C) . Furthermore, mosquito transmission appeared to alter the frequencies 150 of SNPs observed in the ZIKV-PRVABC59 stock virus: for example, a mutation at reference 151 nucleotide 3147 causing a methionine-to-threonine substitution at position 220 of NS1 (NS1 152 M220T) was at high frequency in multiple mosquito samples and in all monkeys infected by 153 mosquito bite, but it remained below 15% frequency in the virus stock and in all animals infected 154 by sc injection. Conversely, a C-to-T mutation at nucleotide 5679 encoding NS3 S356F was 155 present in ~65% of stock viruses and in 40-60% of viruses infecting sc-inoculated animals, but 156 this same mutation was detected in only one mosquito pool and is absent from all animals 157 infected by mosquito bite. 158
Mosquitoes feed on small volumes of blood from infected hosts, limiting the size of the viral 159 population founding infection in the vector. Also, during replication in mosquitoes, flaviviruses 160 undergo population bottlenecks as they traverse physical barriers like the midgut 30, 31 . We 161 therefore reasoned that viral genetic diversity in mosquitoes and monkeys infected by mosquito 162 bite would be low as compared with the virus stock and populations in sc-inoculated monkeys. 163
To test this prediction, we measured within-host viral diversity using the π statistic, which 164 quantifies the number of pairwise differences between sequences without regard to a specific 165 reference. We calculated π for each gene encoding a mature viral protein in each sample 166 (except for protein 2K and NS4A, where coverage was not deep enough in each sample to 167 allow for rigorous comparisons). Consistent with our expectations, our analysis showed that viral 168 diversity tended to be lowest in infected mosquitoes, and highest in the virus stock and sq-169 inoculated animals (Supplemental Figure 1) . Differences in diversity were most pronounced in 170 the capsid gene, where π was significantly lower in mosquito pools and mosquito-infected 171 monkeys than in monkeys inoculated sc, but significant differences between groups were also 172 found in most other viral genes (Supplemental Figure 1) . Finally, we asked how natural 173 selection might be shaping virus populations in infected mosquitoes and monkeys. The 174 magnitude and direction of natural selection on virus populations can be inferred by comparing 175 within-host levels of synonymous and nonsynonymous nucleotide diversity, denoted 176 respectively as πS and πN. In general, πS > πN indicates that purifying selection is acting to 177 remove deleterious mutations, while πS < πN indicates that positive or diversifying selection is 178 acting to favor the outgrowth of new viral variants. We therefore compared the magnitude of πN 179 and πS in each viral gene across experimental groups. πS was significantly greater than πN in 180 multiple nonstructural genes in sc-inoculated monkeys, suggesting that virus populations were 181 largely under purifying selection ( Supplementary Figure 2) . In contrast, we find evidence for 182 purifying selection in mosquito-infected monkeys only in capsid and NS5, and only in NS5 in 183 mosquitoes themselves. Taken together, our data show that ZIKV populations in mosquito-184 infected monkeys exhibit more inter-host variability (i.e., different combinations of SNPs) than in 185 sc-inoculated monkeys, perhaps due to sharp viral population reductions during mosquito 186 infection. We do not find evidence for strong natural selection acting at the gene level in 187 mosquitoes or mosquito-infected monkeys, suggesting that reduced diversity results from 188 random population bottlenecks rather than selection for particular variants. 189
ZIKV-infected rhesus macaques do not develop sufficient viremia to infect mosquitoes. 190
To better understand ZIKV transmission dynamics, Ae. aegypti vector competence for ZIKV 191 from macaques was evaluated at days 7, 13, and 25 d PF from mosquitoes that fed on sc-192 inoculated animals and days 13 and 25 from mosquitoes that fed on mosquito-infected animals. 193
All samples from mosquitoes that fed on sc-inoculated animals were negative for ZIKV by 194 plaque assay at all time points (Table 3) . A single Ae. aegypti that fed on animals infected by 195 mosquito bite had a disseminated ZIKV infection at d 25 PF, but this mosquito was not capable 196 of transmitting the virus as measured by plaque assay (Table 3 ). These data are consistent with 197 field epidemiological reports, which estimated mosquito infection rates during ZIKV outbreaks to 198 be 0.061% 32 and also are consistent with infection rates during DENV and chikungunya 199 outbreaks 33 . It should also be noted that Ae. aegypti with poor competence but high population 200 density have been capable of sustaining outbreaks of arboviral diseases such as yellow fever 34 . 201
DISCUSSION 202
In 1956 in Nigeria, investigators attempted to transmit ZIKV to a healthy rhesus monkey by 203 exposing it to mosquitoes that had fed on ZIKV-infected mouse blood. The animal remained 204 healthy, and no virus was detected in blood, but the animal apparently developed antibodies to 205 ZIKV (no data were shown). As a result, it was concluded that ZIKV transmission was 206 achieved 27 . But beyond this single manuscript, mosquito-bite delivery of ZIKV for laboratory 207 studies has not been reported in the literature. Here we demonstrate, for the first time, to our 208 knowledge, that systemic infection in nonhuman primates can result from mosquito-bite delivery 209 of ZIKV. This work thus establishes a nonhuman primate model for vector-borne ZIKV 210 transmission. Using this model, we observed a significant delay to peak viremia when virus was 211 delivered by mosquito as compared to subcutaneous needle inoculation. While viral genetic 212 composition and diversity levels in sc-inoculated monkeys largely mirrored those of the stock 213 virus, we observed a trend toward decreased genetic diversity in virus populations infecting 214 mosquitoes and the monkeys infected by them. Mosquito infection appeared to alter the 215 frequencies of SNPs in the ZIKV population as compared with the stock virus. We found no 216 evidence that selection favored specific variants in mosquito transmission; instead, we observed 217 a more heterogeneous distribution of viral SNPs in mosquito-infected monkeys than in sc-218 inoculated animals. These findings are consistent with the observation that arboviruses undergo 219 multiple population bottlenecks in infected mosquitoes 30, 31 ; as a result, different mosquitoes 220 could transmit different founder populations to different macaques. The low number of viral 221 genome copies isolated from mosquito saliva, together with the differing patterns of SNPs 222 observed among mosquito-bitten macaques, are also consistent with the interpretation that 223 mosquito transmission involves a random viral population bottleneck. A recent study of DENV 224 evolution in mosquitoes found evidence for both random population bottlenecks and purifying 225 selection as the virus replicated in mosquitoes and crossed anatomical barriers 30 . Our data 226 reveal only limited evidence of purifying selection on ZIKV populations sequenced from 227 mosquito saliva (indeed, we observed the strongest signals of purifying selection in viruses 228 infecting sc-inoculated monkeys), but our study investigated virus populations at single 229 timepoints in infected macaques and mosquitoes and was therefore not powered to carefully 230 evaluate within-host selection on virus populations over time. There is no evidence in our data 231 suggesting that differences in the genetic composition of viruses infecting mosquito-bitten 232 macaques resulted in phenotypic differences in, e.g., disease severity or dissemination of virus 233 to different tissues, but if the source virus population encoded broader phenotypic diversity it is 234 possible that founder effects associated with mosquito transmission could result in 235 phenotypically different infections in different hosts. 236
It is well established that mosquito transmission can affect arbovirus infection outcomes, but 237 outcomes vary depending on the mosquito-virus-host system 11, 12, 17, 35 . In this study we found a 238 single sc dose of 1 x 10 4 PFU of ZIKV led to similar tissue distribution as observed in mosquito-239 inoculated animals at 15 dpi. Although a single sc inoculation may not perfectly model vector-240 borne transmission of ZIKV, we anticipate that sc inoculation will continue to be valuable for 241 studying ZIKV pathogenesis. Needle inoculation remains an important option when it is 242 necessary to control the exact dose delivered, but the dose and number of sc inoculations could 243 alter virus distribution and replication kinetics. For example, several recent studies using needle 244 inoculation detected a broad ZIKV RNA tissue distribution, including in reproductive organs, the 245 CNS, and brain 7, 26, 36, 37 . Likewise, we also found evidence of ZIKV infection of the brain and eye 246 in our needle inoculated animals. In contrast, animals challenged by mosquito bite had no 247 evidence of infection of the brain or CNS 15 dpi. Furthermore, similar to what has been 248 described for human infections (i.e., that most cases are asymptomatic), none of the animals 249 studied here displayed any of the hallmark symptoms (e.g., fever, maculopapular rash, 250 conjunctivitis, etc.) that have been associated with overt Zika fever or those that have been 251 associated with neurologic disease in adults in rare instances (e.g., Guillain-Barré 252 syndrome 38, 39 , encephalitis, meningoencephalitis, and myelitis 40 ); therefore, outcomes observed 253 here may more closely parallel what has been reported during adult human infections. 254
It is theoretically possible that the differences in disease outcomes and virus distribution 255 observed in our study relative to the other studies may be due to the use of a specific strain, 256 dose, or host species. However, many of the published studies used the same Puerto Rican 257 ZIKV strain used in our study. Asian/American lineage outbreak strains share >99% genome-258 wide nucleotide identity 41 , but virus stocks prepared at different centers, while nominally the 259 same strain, have different passage histories, which could result in small, but biologically 260 important, genotypic and phenotypic differences. Another possible explanation for the disparity 261 in outcomes is the inoculation route. For example, iv inoculation likely resulted in antigen 262 presentation to many lymph nodes simultaneously, likely promoting faster innate immune 263 responses and faster clearance of virus from the peripheral blood 7 . Subcutaneous inoculation, 264 by contrast, likely resulted in slower dissemination through the draining lymph nodes; 265 dissemination may be slower still following mosquito infection, as indicated by the delay in peak 266 viral loads observed with mosquito-bite delivery of virus in this study. In addition, the use of 267 multiple simultaneous injections 36 could iatrogenically cause disease signs 17 . For example, the 268 fever response observed with multiple injections might be expected, given that injection of virus 269 stocks also delivers cell culture medium components that might serve as irritants; needle 270 puncture of the skin is also more traumatic than insertion of a mosquito proboscis. Accordingly, 271 needle inoculation of DENV resulted in significantly elevated temperatures in the humanized 272 mouse model as compared to mice infected with DENV via mosquito bite 17 . Notably, our sc-273 inoculated animals did not have elevated body temperatures. 274 Surprisingly, in our experiments no Ae. aegypti (with the exception of a single mosquito that fed 275 on a mosquito-bite inoculated animal) became infected with ZIKV after feeding on ZIKV-viremic 276 macaques. This was likely the result of the low amount of infectious virus in macaque blood. 277
Our previous studies indicate that the PFU:particle ratio for ZIKV in our system is ~1:1000 2 and 278 therefore infectious bloodmeal titers for mosquito feeding experiments were <4.0 log 10 PFU/ml. 279
It is likely that mosquito vectors do not become efficiently infected when ZIKV titers are low, and 280 higher viral titers in the bloodmeal increase the probability of mosquito infection 42 . The exact 281 threshold viremia that results in productive mosquito infection remains unknown, but a recent 282 study used artificial membrane feeding to establish a minimum infective dose of 4.2 log 10 283 PFU/ml for susceptibility in mosquitoes 42 . It should be noted that viral loads in macaque plasma 284 resemble those reported in humans in endemic areas 32, [43] [44] [45] 45, 46 . Furthermore, the first clinical 285 description of a patient suffering from Zika fever was reported in 1956, and was based on a 286 ZIKV infection experimentally induced in a human volunteer 47 . The patient was a 34-year-old 287
European male infected sc with 265 50% mouse lethal doses of the strain of ZIKV isolated in 288 Nigeria in 1954. His first symptoms were fever and a slight headache 3.5 days after inoculation. 289
The headache lasted approximately two days. A rash was not recorded. The patient also was 290 exposed to female Ae. aegypti mosquitoes during the acute stage of illness, and similar to what 291 is described here, ZIKV was not recovered from these mosquitoes, perhaps due to low 292 viremia 47 . 293
We established a mosquito infection model of ZIKV in nonhuman primates to understand the 294 impact of mosquito transmission on ZIKV pathogenesis. Here we used the rhesus macaque 295 because it is a well-studied translational model for viral pathogenesis and for preclinical 296 evaluation of countermeasures, including during pregnancy. However, the approaches we 297 describe to achieve mosquito transmission of ZIKV in the laboratory have many other 298 applications. For example, mosquito transmission models using New-World NHP could help 299 predict the likelihood of establishing sylvatic ZIKV cycles in the Americas. Parallel studies 300 should also evaluate vector competence of New World mosquito species, particularly those 301 vectors that may have the capacity to maintain sylvatic cycles (e.g., Sabethes spp. and 302 Haemogogus spp.) and those that may be capable of bridging sylvatic and urban cycles (e.g., 303
Aedes albopictus) 48 . These mosquito species may have a lower threshold to infection as 304 compared to Ae. aegypti, but this will require further laboratory confirmation. 305
Needle inoculation of arboviruses does not faithfully recapitulate the complex factors involved in 306 vector-borne transmission, which can have important impacts on disease pathogenesis. In our 307 study 4/4 animals were infected in a single feeding session, suggesting that mosquito delivery of 308 ZIKV in nonhuman primates provides a tractable animal model of natural transmission that can 309 be applied to many other mosquito-borne pathogens. For example, studies comparing the 310 course of infection and the immune response between DENVs delivered by mosquito versus 311 needle could be important for defining the quality of the immune response to dengue where both 312 the mosquito vector and enhancing antibodies should be considered 18 . Ultimately, these same 313 approaches may be useful for testing the safety and efficacy of vaccine and therapeutic 314 candidates: previous reports have demonstrated that Leishmania vaccines that protected 315 against needle challenge failed against sandfly-bite challenge 49, 50 and a blood-stage malaria 316 vaccine was shown to be ineffective against mosquito-bite challenge in humans 51 , underscoring 317 the importance of studying pathogenic outcomes following natural exposure to a pathogen. 318
Eventually these approaches could even be extended beyond mosquitoes to pathogens whose 319 vectors share similar blood feeding strategies, such as tick-borne viruses. 320 Madison, WI) and maintained at the University of Wisconsin-Madison as previously described 52 . 360 Ae. aegypti LVP are ZIKV transmission competent 28 . 361 Subcutaneous inoculations. The ZIKV-PR stock was thawed, diluted in PBS to 1 x 10 4 362 PFU/mL, and loaded into a 3mL syringe maintained on ice until inoculation. For subcutaneous 363 inoculations (sc), each of three Indian-origin rhesus macaques was anesthetized and inoculated 364 subcutaneously over the cranial dorsum with 1mL virus stock containing 1 x 10 4 PFU. All 365 animals were closely monitored by veterinary and animal care staff for adverse reactions and 366 signs of disease. Animals were examined, and blood, urine, oral swabs, and saliva were 367 collected from each animal daily from 1 through 10 days, and 14 days post inoculation (dpi), and 368 beginning on the fifteenth day animals were humanely euthanized and necropsied. 369
MATERIALS AND METHODS
Mosquito bite challenges. Mosquitoes were exposed to ZIKV by feeding on isoflurane 370 anesthetized ZIKV-infected Ifnar-/-mice, which develop sufficiently high ZIKV viremia to infect 371 mosquitoes 28, 29 . Ifnar-/-on the C57BL/6 background were bred in the pathogen-free animal 372 facilities of the University of Wisconsin-Madison School of Veterinary Medicine. Two male and 373 two female four-week-old mice were used for mosquito exposures. Mice were inoculated in the 374 left, hind foot pad with 1 x 10 6 PFU of ZIKV in 50 µl of sterile PBS. Three-to six-day-old female 375 mosquitoes were allowed to feed on mice two days post infection at which time sub-mandibular 376 blood draws were performed and serum was collected to verify viremia. These mice yielded an 377 infectious bloodmeal concentration of 5.64 log 10 PFU per ml ± 0.152 (mean ± standard 378 deviation). Mosquitoes that fed to repletion were randomized, separated into cartons in groups 379 of 10-50, and maintained on 0.3 M sucrose in an environmental chamber at 26.5°C ± 1°C, 75% 380 ± 5% relative humidity, and with a 12 hour photoperiod within the Department of Pathobiological 381 Sciences BSL3 Insectary Facility at the University of Wisconsin-Madison. Eleven days later, 382
following oviposition, ZIKV-exposed mosquitoes were sucrose starved for 14 to 16 hours and on 383 the twelfth day mosquitoes were exposed to naive, ketamine anesthetized macaques. The 384 mesh top of a 0.6 L carton containing 10-50 ZIKV-exposed mosquitoes (numbers varied to 385 ensure feeding success) was placed in contact with the left forearm of each of four macaques. 386
The forearm was chosen because there was little hair to obstruct mosquito feeding, it could 387 easily be placed on top of the mosquito carton, and mosquitoes could be easily monitored 388 during the feeding. Mosquitoes were allowed to probe and feed on the forearm for five minutes. 389
Mosquitoes were monitored during feedings and the number of mosquitoes that probed and the 390 blood engorgement status of each mosquito were recorded. ZIKV infection, dissemination, and 391 transmission status was confirmed in a subset of 40 mosquitoes as described in a subsequent 392 section. As described previously, animals were examined, and blood, urine, and oral swabs 393 were collected from each animal daily during challenge. Non or the mosquito-bite challenged 394 animals exhibited cutaneous reactions to mosquito bites and bites were not associated with 395 itching. 396 Vector competence. Infection, dissemination, and transmission rates were determined for 397 individual mosquitoes and sample sizes were chosen using long established procedures 28,29,43 . 398 Mosquitoes that fed to repletion on macaques were randomized and separated into cartons in 399 groups of 40-50 and maintained as described in a previous section. All samples were screened 400 by plaque assay on Vero cells. Dissemination was indicated by virus-positive legs. Transmission 401 was defined as release of infectious virus with salivary secretions, i.e., the potential to infect 402 another host, and was indicated by virus-positive salivary secretions. 403
Plaque assay. All ZIKV screens from mosquito tissues and titrations for virus quantification 404 from mouse serum or virus stocks were completed by plaque assay on Vero cell cultures. 405
Duplicate wells were infected with 0.1 ml aliquots from serial 10-fold dilutions in growth media 406 and virus was adsorbed for one hour. Following incubation, the inoculum was removed, and 407 monolayers were overlaid with 3 ml containing a 1:1 mixture of 1.2% oxoid agar and 2X DMEM 408 (Gibco, Carlsbad, CA) with 10% (vol/vol) FBS and 2% (vol/vol) penicillin/streptomycin. Cells 409 were incubated at 37 °C in 5% CO 2 for four days for plaque development. Cell monolayers then 410 were stained with 3 ml of overlay containing a 1:1 mixture of 1.2% oxoid agar and 2X DMEM 411 with 2% (vol/vol) FBS, 2% (vol/vol) penicillin/streptomycin, and 0.33% neutral red (Gibco). Cells 412 were incubated overnight at 37 °C and plaques were counted. 413 Viral RNA isolation. Plasma was isolated from EDTA-anticoagulated whole blood collected the 414 same day by Ficoll density centrifugation at 1860 rcf for 30 minutes. Plasma was removed to a 415 clean 15mL conical tube and centrifuged at 670 rcf for an additional 8 minutes to remove 416 residual cells. Viral RNA was extracted from 300μL plasma using the Viral Total Nucleic Acid Kit 417 Tissue Kit, the TissueLyser (Qiagen, Hilden, Germany) and two 5 mm stainless steel beads 423 (Qiagen, Hilden, Germany) in a 2 ml snap-cap tube, shaking twice for 3 minutes at 20 Hz each 424 side. The isolation was continued according to the Maxwell 16 LEV simplyRNA Tissue Kit 425 protocol, and samples were eluted into 50 µl RNase free water. RNA was then quantified using 426 quantitative RT-PCR. If a tissue was negative by this method, a duplicate tissue sample was 427 extracted using the Trizol TM Plus RNA Purification kit (Invitrogen, Carlsbad, CA). Because this 428 purification kit allows for more than twice the weight of tissue starting material, there is an 429 increased likelihood of detecting vRNA in tissues with low viral loads. RNA then was re-430 quantified using the same quantitative RT-PCR assay. Viral load data from plasma are 431 expressed as vRNA copies/mL. Viral load data from tissues are expressed as vRNA copies/mg 432 tissue. 433 Rican strain used in the infections described in this manuscript. 448
Quantitative reverse transcription PCR (qRT-PCR). For
Macaque necropsy. Following infection with ZIKV-PR via sc-inoculation or mosquito-bite, 449 macaques were sacrificed at ~15 days post-feeding or post needle inoculation for all animals. 450
Tissues were carefully dissected using sterile instruments that were changed between each 451 organ and tissue type to minimize possible cross contamination. Unfortunately, tissues from one 452 subcutaneously inoculated animal (634675) were not collected with sterile instruments and was 453 therefore excluded from tissue analysis. For each of the two remaining animals infected by sc-454 inoculation (566628 and 311413) and all four animals infected by mosquito bite, each 455 organ/tissue was evaluated grossly in situ, removed with sterile instruments, placed in a sterile 456 culture dish, weighed, and further processed to assess viral burden and tissue distribution or 457 banked for future assays. Sampling of key organ systems suspected as potential tissue 458 reservoirs for ZIKV and associated biological samples included the CNS (brain and eyes), 459 urogenital, hematopoietic, and respiratory systems. A comprehensive listing of all specific 460 tissues collected and analyzed is presented in Table 1 . 461
Deep sequencing. Virus populations replicating in macaque plasma or mosquito saliva were 462 sequenced in duplicate using a method adapted from Quick et. al. 54 . Viral RNA was isolated 463 from mosquito saliva or plasma using the Maxwell 16 Total Viral Nucleic Acid Purification kit, 464 according to manufacturer's protocol. Viral RNA then was subjected to RT-PCR using the 465 SuperScript IV Reverse Transcriptase enzyme (Invitrogen, Carlsbad, CA). Input viral RNA 466 ranged from 294 to 64745 viral RNA templates per cDNA reaction (Supplementary Table 3 ). 467
The cDNA was then split into two multi-plex PCR reactions using the PCR primers described in 468 
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